Latest news with #spineSurgery
Globe and Mail
3 days ago
- Business
- Globe and Mail
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call. Event Date: Thursday, August 28, 2025 Time: 1:30 PM Pacific Time Participant Registration: A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website here. About Carlsmed Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. Investor Relations IR@ Media
Yahoo
19-06-2025
- Business
- Yahoo
Why This Beaten Down Biotech Stock Might Be a Hidden Gem
In the volatile biotech industry, it is easy to overlook small-cap medical device companies, particularly those that are not yet profitable. But every now and then, a company slips under the radar despite having the ideal combination of innovation, market opportunity, and long-term strategic execution. One such company is Alphatec Holdings (ATEC), a medical technology firm specializing in advanced spine surgery solutions. Alphatec uses artificial intelligence (AI) technologies to improve surgical precision, automate signal monitoring, and provide intraoperative analytics. While it is not a pure-play AI company, AI is becoming more integrated into its platform, helping to shape the future of spine surgery. Dear Tesla Stock Fans, Mark Your Calendars for June 22 Nvidia Says Quantum Computing Is Nearing an 'Inflection Point.' Here Are the 3 Best Stocks to Buy Now to Profit. Warren Buffett Loves This Cheap Dividend Stock and So Do Company Insiders Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. With consistent revenue growth, ATEC is gradually gaining traction. Valued at a market capitalization of $1.6 billion, Alphatec stock has risen 21% year to date (YTD), outperforming the S&P 500 Index's ($SPX) gain of 2.2% YTD. Long-term investors who are willing to dig deeper may find this beaten-down growth stock to be a hidden gem. Founded in 1990, Alphatec initially focused on spinal implants and surgical instrumentation. However, it is now reimagining spine surgery as a fully integrated experience, with cutting-edge implants, navigation systems, and surgical software. The company's platform is intended to assist spine surgeons in operating with greater precision, reducing complications, shortening patient recovery times, and collecting intraoperative data for better long-term outcomes. Alphatec has achieved double-digit revenue growth lately, owing to increased surgeon adoption and new product launches. In the first quarter of 2025, total revenue increased 22% year on year to $169 million, with surgical revenue up 24%. Procedure volume is increasing as more surgeons use Alphatec's approaches. The company is quickly becoming a preferred partner for spine surgeons because of its technological capabilities. In Q1, Alphatec experienced an 18% increase in new surgeon adoption. Like most growth companies, Alphatec has yet to turn a profit despite increasing revenues. These losses are largely the result of aggressive reinvestment in growth, research and development (R&D), and surgeon support. During the quarter, the company spent $16.58 million on R&D. Adjusted gross margin reached 70.4% in the quarter. Looking at the firm's consistent revenue growth and margins, profitability may not be far away, especially if the company continues to increase procedure volumes and expand its ecosystem. Adjusted EBITDA stood at $10.5 million in the quarter, up from a $3 million loss in the year-ago quarter. At the end of Q1, Alphatec had $153.2 million in cash and cash equivalents. Management expects adjusted EBITDA of $78 million in 2025, compared to $31 million in the previous year. Analysts covering Alphatec predict that revenue will increase by 20.1% in 2025, in line with management's expectations. Revenue could rise by 18.3% in 2026, with losses gradually declining. The U.S. spine surgery market is large and growing, with a projected value of $20 billion by 2031. Chronic back pain and spinal deformities are on the rise, owing to the aging population and climbing obesity rates. While Alphatec's market share remains small, this allows the company plenty of room to grow. As demand for more precise and less invasive surgeries increases, the few companies like Alphatec with integrated, AI-capable surgical platforms may lead their industry. Of course, growing biotech stocks can be risky. Alphatec faces stiff competition from larger, established players in the medical technology industry, such as Intuitive Surgical (ISRG), Stryker (SYK), and Medtronic (MDT). Furthermore, continued losses may necessitate additional capital raises or risk share dilution. For a company in its early growth stages, however, these risks are manageable, especially given Alphatec's strong traction with both products and customers. Its sole focus on spine surgery also distinguishes the firm as an expert in its field, which is also known as a moat. Still, because Alphatec is a growing biotech company, ATEC is better suited for aggressive investors willing to hold the stock until it reaches its full potential. Last month, H.C. Wainwright analyst Sean Lee reiterated his 'Buy' rating on ATEC stock, citing the company's strong Q1 2025 performance and growth trajectory. Lee emphasized Alphatec's improved profitability, citing consecutive quarters of positive adjusted EBITDA and a decrease in cash burn. The company now expects positive cash flow by year-end, with a projected increase in adjusted EBITDA for 2025. Despite regulatory and financial risks, Lee believes Alphatec is well-positioned for long-term growth. Backed by valuation metrics like EV-to-sales and DCF analysis, Lee set a 12-month price target of $20 per share. Separately, Barclays also maintained a 'Buy' rating on ATEC with a price target of $21. Recently, Lake Street initiated coverage of ATEC stock with a price target of $18 and a 'Buy' rating. According to the analyst, Alphatec is the only major spine company fully committed to improving spinal surgery outcomes, while the rest of the industry appears disorganized or uncertain. Lake Street also predicts that Alphatec's exceptional growth rate will continue. On Wall Street, ATEC is rated a 'Strong Buy' by consensus. Of the 11 analysts covering the stock, nine have rated it a 'Strong Buy' while one analyst recommends a 'Moderate Buy' rating and one rates the stock a 'Hold.' Based on its mean price target of $18.32, Wall Street expects the stock to climb as high as 66% from current levels. Furthermore, the Street-high estimate of $22.50 per share implies potential upside of nearly 105% over the next 12 months. On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-05-2025
- Health
- Yahoo
Joseph Spine Institute Highlights Benefits of Cervical Disc Replacement Over Traditional Fusion Surgery
TAMPA BAY, Fla., May 22, 2025 /PRNewswire/ -- Dr. Sean Kelly, spine surgeon at Joseph Spine Institute, is raising awareness about cervical disc replacement, an advanced surgical option that is proving to be a better alternative to spinal fusion for many patients suffering from degenerative disc disease in the neck. In a newly published article, Dr. Kelly explains how cervical disc replacement preserves natural motion in the cervical spine while relieving pressure on nerves and reducing pain. The procedure is a modern, motion-preserving alternative to traditional spinal fusion, which permanently fuses two or more vertebrae and can result in long-term stiffness and additional stress on surrounding discs. "Spinal fusion is effective, but it limits movement and can accelerate wear and tear in other areas of the spine," said Dr. Kelly. "Cervical disc replacement allows us to maintain motion while achieving the same — or even better — pain relief and long-term results in appropriately selected patients." Key benefits of cervical disc replacement include: Preservation of natural neck motion Reduced risk of adjacent segment degeneration Faster recovery times for many patients Elimination of bone grafts and fusion hardware Not all patients are candidates for disc replacement, but those with one or two levels of disc disease, no spinal instability, and who have not responded to conservative care may benefit from this leading-edge approach. Joseph Spine Institute uses state-of-the-art diagnostics and minimally invasive techniques to create personalized treatment plans for each patient. Dr. Kelly emphasizes that a thorough evaluation is essential to determine if disc replacement is appropriate. "Our goal is to get patients back to the life they love — with less pain, more function, and without unnecessary limitations," Dr. Kelly said. To read the full article or learn more about cervical disc replacement, visit About Joseph Spine Institute:Joseph Spine is a center of excellence for spine care, offering advanced diagnostics, minimally invasive surgical techniques, and comprehensive treatment for a wide range of spinal disorders. With locations in Tampa Bay and beyond, the institute is committed to delivering personalized, patient-focused care under the leadership of expert spine surgeons including Dr. Samuel Joseph, Jr. and Dr. Sean Kelly. For press inquiries, interviews, or referrals, please contact:Media RelationsJoseph Spine InstituteEmail: rcarter@ (813) 294-8311 View original content to download multimedia: SOURCE Joseph Spine Institute Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Times of Oman
18-05-2025
- Health
- Times of Oman
First degenerative scoliosis surgery performed at Nizwa Hospital
Nizwa: A specialised medical team from the Spine Unit at Khoula Hospital, in collaboration with a medical team at Nizwa Hospital, successfully performed the first surgical procedure to treat a case of degenerative scoliosis at Nizwa Hospital. This achievement is part of ongoing efforts to enhance medical cooperation and localize specialised healthcare services in the governorates' health institutions. Dr. Sultan Saif Al Kalbani, Head of the Spine Unit at Khoula Hospital, Consultant in Orthopedic and Spine Surgery, and leader of the medical team, explained to Oman News Agency (ONA) that the surgery was performed on a patient suffering from an abnormal curvature of the spine, using the latest surgical techniques. He clarified that degenerative scoliosis occurs in elderly patients due to the deterioration of cartilage, joints, and ligaments in the back, leading to curvature and severe back pain during movement. He noted that this type of scoliosis differs from the scoliosis that affects children. Dr. Al-Kalbani emphasised that this accomplishment is the result of joint coordination between Khoula Hospital, the national reference center for spine surgeries, and Nizwa Hospital, in line with the Ministry of Health's strategy to enhance specialised services across various governorates of the Sultanate of Oman and reduce pressure on central referral hospitals. He pointed out that such procedures were previously conducted outside the governorate, imposing financial and psychological burdens on patients and their families. However, localising these services helps alleviate these challenges and promotes equitable healthcare distribution among governorates. He also highlighted the importance of collaboration between health institutions to exchange expertise and build national competencies capable of performing complex surgeries. Dr. Al-Kalbani noted the Spine Unit's commitment to advancing spine surgery services in accordance with the latest global practices, with a focus on continuous training and upskilling of medical personnel. It is worth mentioning that Khoula Hospital serves as a centre for treating all types of scoliosis.
